$2.23T
Total marketcap
$124.83B
Total volume
BTC 50.17%     ETH 15.68%
Dominance

Boiron SA BOI.PA Stock

34.15 EUR {{ price }} -0.870825% {{change_pct}}%
COUNTRY
France
Exchange
Paris
Market Cap
593.4M EUR
LOW - HIGH [24H]
34.15 - 34.85 EUR
VOLUME [24H]
2.94K EUR
{{ volume }}
P/E Ratio
12.46
Earnings per share
2.74 EUR

Boiron SA Price Chart

Boiron SA BOI.PA Financial and Trading Overview

Boiron SA stock price 34.15 EUR
Previous Close 38.45 EUR
Open 38.65 EUR
Bid 0 EUR x 0
Ask 0 EUR x 0
Day's Range 38.35 - 38.65 EUR
52 Week Range 37 - 53.2 EUR
Volume 465 EUR
Avg. Volume 7.46K EUR
Market Cap 678.97M EUR
Beta (5Y Monthly) 0.408812
PE Ratio (TTM) 13.508773
EPS (TTM) 2.74 EUR
Forward Dividend & Yield 1.1 (2.84%)
Ex-Dividend Date June 1, 2023
1y Target Est 48.7 EUR

BOI.PA Valuation Measures

Enterprise Value N/A
Trailing P/E 13.508773
Forward P/E 12.962963
PEG Ratio (5 yr expected) -7.46
Price/Sales (ttm) 1.270902
Price/Book (mrq) 1.2551756
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Boiron SA Stock Price History

Beta (5Y Monthly) 0.408812
52-Week Change -5.41%
S&P500 52-Week Change 20.43%
52 Week High 53.2 EUR
52 Week Low 37 EUR
50-Day Moving Average 39.02 EUR
200-Day Moving Average 43.34 EUR

BOI.PA Share Statistics

Avg. Volume (3 month) 7.46K EUR
Avg. Daily Volume (10-Days) 11.91K EUR
Shares Outstanding 17.36M
Float N/A
Short Ratio N/A
% Held by Insiders 75.48%
% Held by Institutions 9.13%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.1
Trailing Annual Dividend Yield 2.86%
5 Year Average Dividend Yield 293.00%
Payout Ratio 0.32869998
Last Split Factor 4:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 8.36%
Operating Margin (ttm) 12.80%
Gross Margin 71.07%
EBITDA Margin 16.78%

Management Effectiveness

Return on Assets (ttm) 5.48%
Return on Equity (ttm) 8.13%

Income Statement

Revenue (ttm) 534.24M EUR
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) 4.59%
Gross Profit (ttm) 379.73M EUR
EBITDA 89.69M EUR
Net Income Avi to Common (ttm) 44.67M EUR
Diluted EPS (ttm) 2.85
Quarterly Earnings Growth (yoy) -15.59%

Balance Sheet

Total Cash (mrq) 250.94M EUR
Total Cash Per Share (mrq) N/A
Total Debt (mrq) 22.17M EUR
Total Debt/Equity (mrq) 3.98 EUR
Current Ratio (mrq) 3.119
Book Value Per Share (mrq) 30.673

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Boiron SA

Country France
State N/A
City Messimy
Address 2, avenue de l’Ouest Lyonnais
ZIP 69510
Phone 33 4 78 45 61 00
Website https://www.boiron.fr
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 2801

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Q&A For Boiron SA Stock

What is a current BOI.PA stock price?

Boiron SA BOI.PA stock price today per share is 34.15 EUR.

How to purchase Boiron SA stock?

You can buy BOI.PA shares on the Paris exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Boiron SA?

The stock symbol or ticker of Boiron SA is BOI.PA.

Which industry does the Boiron SA company belong to?

The Boiron SA industry is Drug Manufacturers-Specialty & Generic.

How many shares does Boiron SA have in circulation?

The max supply of Boiron SA shares is 17.38M.

What is Boiron SA Price to Earnings Ratio (PE Ratio)?

Boiron SA PE Ratio is 12.46350400 now.

What was Boiron SA earnings per share over the trailing 12 months (TTM)?

Boiron SA EPS is 2.74 EUR over the trailing 12 months.

Which sector does the Boiron SA company belong to?

The Boiron SA sector is Healthcare.

Boiron SA BOI.PA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
CAC Mid & Small MS190 14267.59 EUR 15596.4 USD
-0.38
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN 1704.47 GBP 2179.91 USD
0
1704.47 GBP 2179.91 USD 1704.47 GBP 2179.91 USD
CAC Small CS90 11739.13 EUR 12832.46 USD
-0.74